What is the typical dose of propranolol (beta-blocker) for anxiety-related tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing for Anxiety-Related Tachycardia

For anxiety-related tachycardia, start propranolol immediate-release at 10-40 mg three to four times daily (total 30-160 mg/day), titrating based on symptom control and heart rate response. 1

Initial Dosing Strategy

  • Begin with propranolol immediate-release 10-40 mg three to four times daily, as recommended by the American College of Cardiology for symptomatic tachyarrhythmias 1
  • For patients preferring once-daily dosing, the long-acting formulation can be started at 80 mg once daily, with titration to 120-160 mg daily for maintenance 1
  • Improvement in somatic symptoms (tremor, palpitations) occurs within 1-2 hours at relatively low doses (40 mg/day) 2

Dose Titration and Optimization

  • Most patients with anxiety achieve adequate symptom control with 80-320 mg daily of immediate-release propranolol 3
  • The target is to achieve virtual abolition of orthostatic and hyperventilatory tachycardia, indicating adequate beta-blockade 3
  • Approximately 50% of patients achieve clinically significant reduction in exercise tachycardia (≥20 bpm decrease) with 160 mg per day 4
  • Only one-third of patients respond adequately at doses ≤160 mg/day, while an additional 40% require 200-640 mg/day for optimal effect 5
  • Plasma propranolol levels above 20 ng/ml are needed to induce significant beta-blockade, typically achieved with daily doses slightly exceeding 160 mg 4

Mandatory Pre-Treatment Screening

Before initiating propranolol, you must screen for absolute contraindications:

  • Cardiogenic shock or hypotension 1
  • Active asthma or obstructive airway disease 1
  • Perform baseline cardiovascular examination with auscultation 1

Monitoring During Treatment

  • Watch for hypotension and bradycardia, especially during dose escalation 1
  • In diabetic patients, counsel that propranolol may mask hypoglycemia symptoms (tremor, tachycardia) 1
  • Assess symptom response at each visit and adjust dosing accordingly 1

Critical Safety Warnings

  • Never abruptly discontinue propranolol after chronic use—taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 1
  • Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to severe bradycardia and heart block risk 1
  • Some patients exhibit a biphasic dose-response curve, where arrhythmia frequency decreases at lower doses but paradoxically increases at higher doses above the optimal level 5

Long-Term Considerations

  • With sustained treatment at higher doses (160 mg/day), improvement in psychic anxiety symptoms may emerge after several weeks, beyond the immediate somatic symptom relief 2
  • Propranolol requirements often diminish over time, and lasting remissions are not infrequent 3
  • Depression, present in approximately 50% of anxiety patients, usually improves with propranolol but may persist in one-third as a lone symptom requiring antidepressant therapy 3

Alternative Formulation for Acute Situations

  • For acute anxiety episodes requiring rapid control, IV propranolol can be given as 1 mg over 1 minute, repeated every 2 minutes up to 3 doses maximum 1

References

Guideline

Propranolol Dosing for Palpitations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Propranolol in the treatment of anxiety.

Postgraduate medical journal, 1976

Research

Propranolol dosage, plasma concentration, and beta blockade.

Clinical pharmacology and therapeutics, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.